Divyaswathi Citla Sridhar, MD MS/LinkedIn
Nov 20, 2025, 13:56
Glanzmann Thrombasthenia Is More Common Than Previously Thought
Divyaswathi Citla Sridhar, Pediatric Hematologist and Oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:
”Our analysis of 1,059 U.S. patients with Glanzmann Thrombasthenia (GT) shows that GT prevalence may be significantly higher in the United States than previously recognized, and underscores the substantial clinical burden from recurrent bleeding, anemia, and transfusion dependence.
Huge shout-out to my fantastic collaborator, Daniel Liu, for his expertise in working with this complex dataset.”
Read the full article here.
Title: Characterising Glanzmann Thrombasthenia in the United States: Real-World Data From the EPIC Cosmos Dataset
Authors: Divyaswathi Citla-Sridhar, Daniel Liu

Stay updated with Hemostasis today.
Arkansas Children’s Hospital
bleeding disorders
Daniel Liu
Divyaswathi Citla-Sridhar
EPIC Cosmos Dataset
Glanzmann thrombasthenia
Glanzmann Thrombasthenia Support Group
Glanzmann's Research Foundation
haemophilia
Health
Hematology
Hemostasis
Hemostasis Today
Inherited Bleeding Disorder
Medicine
thrombosis
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
